PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 167 filers reported holding PRECIGEN INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,092 | +24.6% | 229,642 | +0.9% | 0.00% | – |
| Q2 2023 | $261,632 | +9.8% | 227,506 | +1.2% | 0.00% | – |
| Q1 2023 | $238,189 | -30.6% | 224,707 | -0.5% | 0.00% | -100.0% |
| Q4 2022 | $343,379 | -24.5% | 225,907 | +5.3% | 0.00% | 0.0% |
| Q3 2022 | $455,000 | +58.5% | 214,450 | 0.0% | 0.00% | – |
| Q2 2022 | $287,000 | +205.3% | 214,450 | +382.5% | 0.00% | – |
| Q1 2022 | $94,000 | -43.0% | 44,450 | 0.0% | 0.00% | – |
| Q4 2021 | $165,000 | +129.2% | 44,450 | +206.4% | 0.00% | – |
| Q3 2021 | $72,000 | -87.4% | 14,505 | -83.5% | 0.00% | -100.0% |
| Q2 2021 | $573,000 | -56.3% | 87,939 | -53.7% | 0.00% | -66.7% |
| Q1 2021 | $1,310,000 | -20.4% | 190,096 | +17.8% | 0.00% | -25.0% |
| Q4 2020 | $1,646,000 | +221.5% | 161,389 | +10.2% | 0.00% | +300.0% |
| Q3 2020 | $512,000 | -30.4% | 146,389 | -0.7% | 0.00% | -50.0% |
| Q2 2020 | $736,000 | +32.6% | 147,489 | -9.6% | 0.00% | 0.0% |
| Q1 2020 | $555,000 | – | 163,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |